Ionis, Novartis’ key experimental heart drug fails in late-stage trial
Sept 4 (Reuters) – Ionis Pharmaceuticals and partner Novartis’ experimental drug to lower high levels of a cholesterol-carrying particle in heart patients failed in a late-stage trial, the companies said on Friday, sending Ionis’ shares down 12% in aftermarket trading. The drug, pelacarsen, did not meet the main goal of reducing the risk of events such as death from heart disease, heart attack, stroke, or needing an urgent procedure to […]